A detailed history of Met Life Investment Management, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 145,379 shares of PACB stock, worth $223,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145,379
Previous 120,163 20.98%
Holding current value
$223,883
Previous $204,000 30.39%
% of portfolio
0.0%
Previous 0.0%

Shares

55 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$1.55 - $2.65 $39,084 - $66,822
25,216 Added 20.98%
145,379 $266,000
Q3 2024

Nov 13, 2024

SELL
$1.2 - $2.17 $40,795 - $73,771
-33,996 Reduced 22.05%
120,163 $204,000
Q2 2024

Aug 13, 2024

BUY
$1.36 - $3.65 $44,686 - $119,931
32,858 Added 27.09%
154,159 $211,000
Q1 2024

May 14, 2024

BUY
$3.52 - $9.59 $426,979 - $1.16 Million
121,301 New
121,301 $454,000
Q3 2023

May 09, 2024

BUY
$8.23 - $13.93 $14,427 - $24,419
1,753 Added 1.35%
131,795 $1.1 Million
Q2 2023

Apr 29, 2024

BUY
$9.97 - $14.05 $1.31 Million - $1.85 Million
131,795 New
131,795 $1.75 Million
Q2 2023

Aug 10, 2023

BUY
$9.97 - $14.05 $17,477 - $24,629
1,753 Added 1.35%
131,795 $1.75 Million
Q1 2023

May 09, 2024

BUY
$7.94 - $12.02 $1.03 Million - $1.56 Million
130,042 New
130,042 $1.51 Billion
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $96,733 - $146,439
12,183 Added 10.34%
130,042 $1.51 Million
Q4 2022

Jun 14, 2023

SELL
$5.67 - $11.2 $69,077 - $136,449
-12,183 Reduced 9.37%
117,859 $964,000
Q3 2022

Jun 14, 2023

SELL
$3.93 - $8.57 $47,879 - $104,408
-12,183 Reduced 9.37%
117,859 $684,000
Q2 2022

May 10, 2024

BUY
$4.02 - $10.43 $55,849 - $144,903
13,893 Added 13.36%
117,859 $520,000
Q2 2022

Jun 20, 2023

SELL
$4.02 - $10.43 $48,975 - $127,068
-12,183 Reduced 9.37%
117,859 $520,000
Q2 2022

Mar 22, 2023

BUY
$4.02 - $10.43 $55,849 - $144,903
13,893 Added 13.36%
117,859 $520,000
Q2 2022

Aug 11, 2022

BUY
$4.02 - $10.43 $55,849 - $144,903
13,893 Added 13.36%
117,859 $521,000
Q1 2022

May 10, 2024

BUY
$8.43 - $20.9 $876,433 - $2.17 Million
103,966 New
103,966 $946,000
Q1 2022

Jun 20, 2023

SELL
$8.43 - $20.9 $219,820 - $544,988
-26,076 Reduced 20.05%
103,966 $946,000
Q1 2022

Mar 22, 2023

BUY
$8.43 - $20.9 $292,512 - $725,209
34,699 Added 50.09%
103,966 $946,000
Q1 2022

May 12, 2022

BUY
$8.43 - $20.9 $292,512 - $725,209
34,699 Added 50.09%
103,966 $946,000
Q4 2021

Jun 21, 2023

SELL
$19.26 - $30.08 $1.17 Million - $1.83 Million
-60,775 Reduced 46.73%
69,267 $1.42 Million
Q3 2021

Jun 21, 2023

SELL
$24.86 - $35.02 $1.51 Million - $2.13 Million
-60,775 Reduced 46.73%
69,267 $1.77 Million
Q2 2021

May 17, 2024

BUY
$22.3 - $36.02 $56,954 - $91,995
2,554 Added 3.83%
69,267 $2.42 Million
Q2 2021

Jun 21, 2023

SELL
$22.3 - $36.02 $1.36 Million - $2.19 Million
-60,775 Reduced 46.73%
69,267 $2.42 Million
Q2 2021

Mar 22, 2023

BUY
$22.3 - $36.02 $56,954 - $91,995
2,554 Added 3.83%
69,267 $2.42 Million
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $56,954 - $91,995
2,554 Added 3.83%
69,267 $2.42 Million
Q1 2021

May 17, 2024

SELL
$26.38 - $51.15 $1.44 Million - $2.79 Million
-54,588 Reduced 45.0%
66,713 $2.22 Million
Q1 2021

Jun 26, 2023

SELL
$26.38 - $51.15 $1.67 Million - $3.24 Million
-63,329 Reduced 48.7%
66,713 $2.22 Billion
Q1 2021

Mar 22, 2023

SELL
$26.38 - $51.15 $134,221 - $260,251
-5,088 Reduced 7.09%
66,713 $2.22 Million
Q1 2021

May 14, 2021

SELL
$26.38 - $51.15 $134,221 - $260,251
-5,088 Reduced 7.09%
66,713 $2.22 Million
Q4 2020

Jun 22, 2023

SELL
$10.5 - $28.5 $611,530 - $1.66 Million
-58,241 Reduced 44.79%
71,801 $1.86 Million
Q3 2020

May 24, 2024

BUY
$3.61 - $9.87 $23,277 - $63,641
6,448 Added 9.87%
71,801 $709 Million
Q3 2020

Jun 26, 2023

SELL
$3.61 - $9.87 $210,250 - $574,838
-58,241 Reduced 44.79%
71,801 $708,000
Q3 2020

Mar 22, 2023

BUY
$3.61 - $9.87 $23,277 - $63,641
6,448 Added 9.87%
71,801 $708,000
Q3 2020

Nov 13, 2020

BUY
$3.61 - $9.87 $23,277 - $63,641
6,448 Added 9.87%
71,801 $709,000
Q2 2020

May 24, 2024

SELL
$2.65 - $4.03 $148,262 - $225,470
-55,948 Reduced 46.12%
65,353 $225 Million
Q2 2020

Jun 26, 2023

SELL
$2.65 - $4.03 $171,425 - $260,696
-64,689 Reduced 49.74%
65,353 $225,000
Q1 2020

Jul 12, 2023

SELL
$2.36 - $5.26 $152,666 - $340,264
-64,689 Reduced 49.74%
65,353 $199,000
Q1 2020

Mar 22, 2023

BUY
$2.36 - $5.26 $38,224 - $85,196
16,197 Added 32.95%
65,353 $199,000
Q1 2020

May 15, 2020

BUY
$2.36 - $5.26 $38,224 - $85,196
16,197 Added 32.95%
65,353 $200,000
Q4 2019

Jul 12, 2023

SELL
$4.6 - $5.57 $372,075 - $450,535
-80,886 Reduced 62.2%
49,156 $252,000
Q4 2019

Mar 22, 2023

SELL
$4.6 - $5.57 $81,125 - $98,232
-17,636 Reduced 26.4%
49,156 $252,000
Q4 2019

Feb 14, 2020

SELL
$4.6 - $5.57 $81,125 - $98,232
-17,636 Reduced 26.4%
49,156 $253,000
Q3 2019

Jul 12, 2023

SELL
$4.99 - $6.16 $315,617 - $389,620
-63,250 Reduced 48.64%
66,792 $344,000
Q3 2019

Mar 22, 2023

BUY
$4.99 - $6.16 $45,339 - $55,969
9,086 Added 15.75%
66,792 $344,000
Q3 2019

Nov 14, 2019

BUY
$4.99 - $6.16 $45,339 - $55,969
9,086 Added 15.75%
66,792 $345,000
Q2 2019

Jul 12, 2023

SELL
$5.92 - $7.41 $374,440 - $468,682
-63,250 Reduced 48.64%
66,792 $404,000
Q1 2019

Jul 13, 2023

SELL
$6.8 - $7.4 $491,884 - $535,286
-72,336 Reduced 55.63%
57,706 $417,000
Q4 2018

Jul 13, 2023

SELL
$3.99 - $7.82 $288,620 - $565,667
-72,336 Reduced 55.63%
57,706 $427,000
Q4 2018

Mar 22, 2023

SELL
$3.99 - $7.82 $129,399 - $253,610
-32,431 Reduced 35.98%
57,706 $427,000
Q4 2018

Feb 14, 2019

SELL
$3.99 - $7.82 $129,399 - $253,610
-32,431 Reduced 35.98%
57,706 $427,000
Q3 2018

Jul 13, 2023

SELL
$3.52 - $5.55 $254,622 - $401,464
-72,336 Reduced 55.63%
57,706 $312,000
Q3 2018

Mar 22, 2023

SELL
$3.52 - $5.55 $97,581 - $153,857
-27,722 Reduced 23.52%
90,137 $487,000
Q3 2018

Nov 14, 2018

BUY
$3.52 - $5.55 $110,492 - $174,214
31,390 Added 53.43%
90,137 $488,000
Q1 2018

May 15, 2018

BUY
$2.05 - $3.23 $93,279 - $146,971
45,502 Added 343.54%
58,747 $120,000
Q4 2017

Feb 15, 2018

BUY
$2.59 - $5.44 $34,304 - $72,052
13,245
13,245 $35,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $346M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.